Comparative Pharmacokinetics of the Anticoagulant Effect of Coumarin Drugs in Man and Rat

  • Gerhard Levy


The coumarin anticoagulants are a particularly interesting group of drugs for pharmacokinetic study because their concentration in plasma or serum and their anticoagulant effect can be readily measured. In addition, these drugs are widely used and subject to many clinically important interactions with other drugs. Our interest in the pharmacokinetics of warfarin and dicumarol was stimulated largely by the classical investigations by O’Reilly et al. (1970) and by a collaborative study with him seven years ago (O’Reilly et al., 1966). We became very intrigued by the unusual dose-dependence of the kinetics of dicumarol elimination in man (O’Reilly et al., 1964) and by the fact that the temporal pattern of the anticoagulant effect of the coumarin drugs appears to lag considerably behind the concentrations of these drugs in the plasma. Since nonlinear kinetics of drug elimination (Levy, 1968; Levy et al., 1972; Tsuchiya and Levy, 1972) and kinetics of drug action (Levy, 1966; Levy, 1973) are among our major areas of research, it was only natural to focus on both of these aspects as they pertain to the coumarin anticoagulants. The research on the dose-dependent kinetics of dicumarol elimination has been described in a series of six publications from 1968 (Nagashima et al., 1968) to 1969 (Levy and Nagashima, 1969) and has now been expanded to a general consideration of the role of product inhibition in the dose-dependent elimination of drugs that are subject to hydroxylation (Levy et al., 1972).


Warfarin Dose Racemic Mixture Anticoagulant Effect Individual Enantiomer Coumarin Anticoagulant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Breckenridge, A., and Orme, M., 1972, Life Sci. 11: 337.CrossRefGoogle Scholar
  2. Eble, J. N., West, B. D., and Link, K. P., 1966, Biochem. Pharmacol. 15: 1003.CrossRefGoogle Scholar
  3. Hewick, D. S., 1972, J. Pharm. Pharmacol. 24: 661.PubMedCrossRefGoogle Scholar
  4. Levy, G., 1966, Clin. Pharmacol. Therap. 7: 362.Google Scholar
  5. Levy, G., 1968, in: Importance of Fundamental Principles in Drug Evaluation (Tedeschi, D. H., and Tedeschi, R. E., eds.) Raven Press, New York.Google Scholar
  6. Levy, G., 1973, Proc. Fifth Intern. Congr. Pharmacol., 3: 34.Google Scholar
  7. Levy, G., Ashley, J. J., Jähnchen, E., and Perrier, D., 1972, Abstracts, 13th Nat. Mtg. A.Ph.A. Acad. Pharm. Sci. 2: 179.Google Scholar
  8. Levy, G., and Nagashima, R., 1969, J. Pharm. Sci. 58: 1001.PubMedCrossRefGoogle Scholar
  9. Levy, G., O’Reilly, R. A., Aggeler, P. M., and Keech, G. M., 1970, Clin. Pharmacol, & Therap. 11: 372.Google Scholar
  10. Levy, G., Tsuchiya, T., and Amsel, L. P., 1972, Clin. Pharmacol. Therap. 13: 258.Google Scholar
  11. Nagashima, R., Levy, G., and Nelson, E., 1968, J. Pharm. Sci. 57: 58.PubMedCrossRefGoogle Scholar
  12. Nagashima, R., Levy, G., and Sarcione, E. J., 1968, J. Pharm. Sci. 57: 1881.PubMedCrossRefGoogle Scholar
  13. Nagashima, R., O’Reilly, R. A., and Levy, G., 1969, Clin. Pharmacol. Therap. 10: 22.Google Scholar
  14. O’Reilly, R. A., 1973, Clin. Res. 21: 197.Google Scholar
  15. O’Reilly, R. A., and Aggeler, P. M., 1970, Pharmacol. Rev. 22: 35.PubMedGoogle Scholar
  16. O’Reilly, R. A., Aggeler, P. M., and Leong, L. S., 1964, Thromb, Diath. Haemorrhag. 11: 1.Google Scholar
  17. O’Reilly, R. A., and Levy, G., 1970, Clin. Pharmacol. Therap. 11: 378.Google Scholar
  18. O’Reilly, R. A., Nelson, E., and Levy, G., 1966, J. Pharm. Sci. 55: 435.PubMedCrossRefGoogle Scholar
  19. Tsuchiya, T., and Levy, G., 1972, J. Pharm. Sci. 61: 541.PubMedCrossRefGoogle Scholar
  20. Wingard, L. B., Jr., and Levy, G., 1972, J. Pharmacol. Exp. Therap., 184: 253.Google Scholar

Copyright information

© Springer Science+Business Media New York 1972

Authors and Affiliations

  • Gerhard Levy
    • 1
  1. 1.Department of Pharmaceutics, School of PharmacyState University of New York at BuffaloBuffaloUSA

Personalised recommendations